Cogstate Ltd has released a press release.
Cogstate Establishes Rare Disease and Pediatric Expertise
Filed with ASX ·
Watch Cogstate's latest callCogstate (ASX:CGS) Q4 2026 Earnings Call · Replay · Aug 17Read the transcript of Cogstate (ASX:CGS) Q4 2026 Earnings Call6ix hasn’t read this filing yet.
Earlier from Cogstate
- S&P DJ Indices Announces March Quarterly Rebalance
- Appendix 4D & Half Year Financial Report
- Global Alzheimer Platform Foundation Selects Cogstate
- Interim Business Update
- Cogstate cleared by FDA to start marketing Cognigram in U.S.
Later from Cogstate
- Business Update & Appendix 4C
- Cogstate announces European approval for Cognigram
- AD trial discontinued - limited CGS impact
- Full Year Financial Results Summary
- AGM Presentation
Follow Cogstate into a list and get an email when it puts out news.
Follow Cogstate